- Home
- NSPR vs MCHX Comparison
NSPR vs MCHX Comparison
Compare NSPR & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NSPR
- MCHX
- Stock Information
- Founded
- NSPR 2005
- MCHX 2003
- Country
- NSPR United States
- MCHX United States
- Employees
- NSPR N/A
- MCHX N/A
- Industry
- NSPR Medical/Dental Instruments
- MCHX Business Services
- Sector
- NSPR Health Care
- MCHX Consumer Discretionary
- Exchange
- NSPR Nasdaq
- MCHX Nasdaq
- Market Cap
- NSPR 75.1M
- MCHX 84.3M
- IPO Year
- NSPR N/A
- MCHX 2004
- Fundamental
- Price
- NSPR $2.44
- MCHX $2.05
- Analyst Decision
- NSPR Strong Buy
- MCHX
- Analyst Count
- NSPR 2
- MCHX 0
- Target Price
- NSPR $4.50
- MCHX N/A
- AVG Volume (30 Days)
- NSPR 386.2K
- MCHX 40.2K
- Earning Date
- NSPR 08-05-2025
- MCHX 08-07-2025
- Dividend Yield
- NSPR N/A
- MCHX N/A
- EPS Growth
- NSPR N/A
- MCHX N/A
- EPS
- NSPR N/A
- MCHX N/A
- Revenue
- NSPR $7,027,000.00
- MCHX $47,951,000.00
- Revenue This Year
- NSPR $4.85
- MCHX $5.77
- Revenue Next Year
- NSPR $113.47
- MCHX N/A
- P/E Ratio
- NSPR N/A
- MCHX N/A
- Revenue Growth
- NSPR 8.49
- MCHX N/A
- 52 Week Low
- NSPR $1.99
- MCHX $1.26
- 52 Week High
- NSPR $3.80
- MCHX $2.40
- Technical
- Relative Strength Index (RSI)
- NSPR 54.16
- MCHX 54.23
- Support Level
- NSPR $2.12
- MCHX $2.02
- Resistance Level
- NSPR $2.46
- MCHX $2.20
- Average True Range (ATR)
- NSPR 0.16
- MCHX 0.13
- MACD
- NSPR 0.01
- MCHX -0.03
- Stochastic Oscillator
- NSPR 73.33
- MCHX 33.33
About NSPR InspireMD Inc.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.
About MCHX Marchex Inc. Class B
Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.